COM:VERASTEM
Verastem Oncology
- Stock
Last Close
6.96
07/03 21:00
Market Cap
69.14M
Beta: -
Volume Today
1.27M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -77K - | -77K 0% | 163.50K - | 1.71M 946.79% | 1.55M 9.55% | -50.39M 3,354.91% | -50.39M 0% | ||||
average payables | 2.99M - | 3.58M 19.78% | 4.02M 12.28% | 6.64M 65.25% | 9.72M 46.37% | 9.95M 2.41% | 5.76M 42.08% | 2.09M 63.77% | 3.60M 72.44% | 6.04M 67.78% | |
average receivables | 1.24M - | 1.25M 1.25% | 179K 85.69% | 102K 43.02% | 153K 50% | 1.42M 824.84% | 1.38M 2.37% | 377.50K 72.67% | 273.50K 27.55% | 36.50K 86.65% | |
book value per share | 41.28 - | 34.22 17.10% | 23.46 31.46% | 18.02 23.19% | 22.96 27.45% | 1.15 94.97% | 9.02 681.54% | 6.02 33.22% | 0.24 95.94% | 3.56 1,355.11% | |
capex per share | -1.13 - | -0.07 93.76% | -0.01 82.04% | -4.34 - | -0.00 99.97% | -0.00 129.30% | -0.01 422.17% | 0.00 - | |||
capex to depreciation | -5.69 - | -0.28 95.08% | -0.06 79.20% | -16.57 - | -0.00 99.98% | -0.03 718.52% | -2.72 10,252.69% | 0.11 - | |||
capex to operating cash flow | 0.07 - | 0.00 92.96% | 0.00 71.44% | 0.32 - | 0.00 99.98% | 0.00 1,848.94% | 0.00 271.96% | -0.00 - | |||
capex to revenue | -0.88 - | -0.00 99.95% | -0.00 7.03% | -0.10 25,507.96% | |||||||
cash per share | 43.10 - | 65.34 51.61% | 26.25 59.83% | 27.07 3.14% | 46.12 70.36% | 12.15 73.66% | 11.05 9.03% | 12.33 11.59% | 0.45 96.32% | 6.26 1,279.22% | |
days of inventory on hand | 723.36 - | 402.58 44.35% | |||||||||
days payables outstanding | 22.68K - | 1.26K 94.46% | 20.28 98.38% | 42.29K - | |||||||
days sales outstanding | 4.18 - | 52.78 1,162.49% | 0.99 98.13% | 91.74 9,208.61% | 4.36 95.25% | ||||||
debt to assets | 0.17 - | 0.43 163.10% | 0.74 70.63% | 0.15 80.30% | 0.03 81.53% | 0.28 955.64% | 0.27 3.76% | ||||
debt to equity | 0.26 - | 0.97 276.98% | 14.99 1,446.77% | 0.20 98.70% | 0.03 82.88% | 0.57 1,606.07% | 0.52 8.52% | ||||
dividend yield | 0.00 - | ||||||||||
earnings yield | -0.23 - | -0.87 282.65% | -0.88 1.60% | -0.57 34.65% | -0.33 42.27% | -1.69 410.13% | -0.21 87.75% | -0.23 9.38% | -0.08 64.98% | -0.49 512.58% | |
enterprise value | 201.95M - | -43.42M 121.50% | 9.08M 120.90% | 50.61M 457.50% | 208.86M 312.70% | 163.95M 21.50% | 281.35M 71.61% | 259.54M 7.75% | 881.67M 239.70% | 142.24M 83.87% | |
enterprise value over ebitda | -3.80 - | 0.75 119.65% | -0.25 133.49% | -0.76 203.73% | -2.30 203.23% | -1.30 43.64% | -5.91 355.87% | -4.24 28.30% | -12.30 190.19% | -1.55 87.43% | |
ev to operating cash flow | -5.47 - | 0.95 117.42% | -0.31 132.30% | -0.88 186.82% | -2.80 217.41% | -1.18 57.77% | -8.40 609.44% | -4.85 42.23% | -13.85 185.44% | -1.65 88.12% | |
ev to sales | 7.82 - | 9.39 20.15% | 3.18 66.16% | 126.42 3,877.31% | 339.63 168.65% | ||||||
free cash flow per share | -18.29 - | -15.29 16.43% | -9.58 37.34% | -17.90 86.87% | -18.11 1.16% | -22.29 23.10% | -2.62 88.22% | -3.69 40.76% | -0.33 91.10% | -3.92 1,092.24% | |
free cash flow yield | -0.17 - | -0.68 310.66% | -0.71 4.06% | -0.49 31.82% | -0.45 7.57% | -1.39 208.67% | -0.10 92.59% | -0.15 46.25% | -0.07 54.39% | -0.48 603.04% | |
graham net net | 39.32 - | 61.80 57.18% | 22.62 63.40% | 17.04 24.66% | 17.94 5.26% | -9.48 152.86% | 8.01 184.47% | 7.44 7.08% | 0.21 97.21% | 3.03 1,359.22% | |
graham number | 151.82 - | 121.98 19.66% | 78.99 35.25% | 92.65 17.30% | 83.14 10.26% | 26.59 68.02% | 32.80 23.36% | 27.50 16.15% | 1.45 94.73% | 17.82 1,129.48% | |
income quality | 0.69 - | 0.79 13.86% | 0.81 2.77% | 0.85 4.47% | 1.03 21.71% | 0.93 9.76% | 0.49 46.71% | 0.75 51.89% | 0.86 14.80% | 0.99 14.72% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.08 Infinity% | 0.14 77.24% | 0 100% | 0 | 0 | 0 | |
interest coverage | -121.30 - | -16.31 86.55% | -6.42 60.64% | -3.13 51.33% | -6.16 97.05% | -34.13 454.23% | -22.25 34.82% | ||||
interest debt per share | 4.81 - | 23.32 385.34% | 20.62 11.60% | 3.00 85.45% | 0.89 70.41% | 0.15 83.01% | 2.05 1,258.12% | ||||
inventory turnover | 0.50 - | 0.91 79.68% | |||||||||
invested capital | 0.26 - | 0.97 276.98% | 14.99 1,446.77% | 0.20 98.70% | 0.03 82.88% | 0.57 1,606.07% | 0.52 8.52% | ||||
market cap | 235.85M - | 66.83M 71.66% | 41.43M 38.02% | 117.96M 184.73% | 218.27M 85.05% | 99.93M 54.22% | 326.59M 226.81% | 357.53M 9.47% | 929.54M 159.99% | 179.52M 80.69% | |
net current asset value | 85.43M - | 100.22M 17.31% | 69.96M 30.19% | 55.68M 20.42% | 100.32M 80.18% | -52.91M 152.74% | 105.86M 300.08% | 84.64M 20.05% | 45.21M 46.58% | 72.50M 60.35% | |
net debt to ebitda | 0.64 - | 1.89 197.19% | 0.89 53.00% | 1.01 13.43% | 0.10 89.73% | -0.51 588.21% | 0.95 287.74% | 1.60 68.35% | 0.67 58.27% | 0.41 39.34% | |
net income per share | -24.82 - | -19.32 22.13% | -11.82 38.82% | -21.18 79.12% | -13.38 36.81% | -27.22 103.44% | -5.30 80.53% | -5.58 5.28% | -0.38 93.17% | -3.96 938.84% | |
operating cash flow per share | -17.16 - | -15.22 11.34% | -9.57 37.13% | -17.90 87.12% | -13.76 23.10% | -22.29 61.92% | -2.62 88.23% | -3.68 40.38% | -0.33 91.07% | -3.92 1,092.34% | |
payables turnover | 0.02 - | 0.29 1,706.58% | 18.00 6,090.39% | 0.01 - | |||||||
receivables turnover | 87.31 - | 6.92 92.08% | 370.36 5,255.11% | 3.98 98.93% | 83.74 2,004.77% | ||||||
research and ddevelopement to revenue | 1.63 - | 2.62 60.53% | 0.47 82.18% | 19.17 4,000.11% | 19.48 1.62% | ||||||
return on tangible assets | -0.54 - | -0.51 5.42% | -0.44 14.84% | -0.76 73.30% | -0.28 62.48% | -1.35 377.55% | -0.44 67.57% | -0.75 70.10% | -0.78 4.10% | -0.58 24.89% | |
revenue per share | 4.94 - | 2.81 43.09% | 6.93 146.64% | 0.14 97.96% | 0.01 90.51% | ||||||
roe | -0.60 - | -0.56 6.07% | -0.50 10.74% | -1.18 133.20% | -0.58 50.42% | -23.58 3,946.71% | -0.59 97.51% | -0.93 57.65% | -1.56 68.24% | -1.11 28.61% | |
roic | -0.60 - | -0.56 7.18% | -0.51 8.70% | -0.94 84.21% | -0.54 42.96% | -1.27 135.22% | -0.35 72.31% | -0.75 115.26% | -0.95 26.13% | -0.77 19.38% | |
sales general and administrative to revenue | 2.89 - | ||||||||||
shareholders equity per share | 41.28 - | 34.22 17.10% | 23.46 31.46% | 18.02 23.19% | 22.96 27.45% | 1.15 94.97% | 9.02 681.54% | 6.02 33.22% | 0.24 95.94% | 3.56 1,355.11% | |
stock based compensation to revenue | 0.25 - | 0.49 95.92% | 0.09 81.25% | 3.76 3,995.38% | 2.33 37.98% | ||||||
tangible asset value | 88.77M - | 102.47M 15.44% | 72.30M 29.45% | 57.68M 20.21% | 102.72M 78.08% | -12.83M 112.49% | 115.27M 998.19% | 87.56M 24.04% | 47.39M 45.88% | 78.53M 65.71% | |
tangible book value per share | 41.28 - | 34.22 17.10% | 23.46 31.46% | 18.02 23.19% | 18.98 5.32% | -2.07 110.88% | 9.02 536.87% | 6.02 33.22% | 0.24 95.94% | 3.56 1,355.11% | |
working capital | 86.11M - | 100.80M 17.06% | 70.30M 30.26% | 70.66M 0.50% | 216.18M 205.95% | 55.07M 74.53% | 127.84M 132.15% | 87.15M 31.83% | 71.21M 18.29% | 117.30M 64.73% |
All numbers in USD (except ratios and percentages)